HeartFlow is a medical technology company that provides new methods of diagnosis and treatment of cardiovascular disease. It offers HeartFlow Analysis, a non-invasive solution available in the United States, Europe, and Japan that helps a physician evaluate whether a patient has significant coronary artery disease based on anatomy and physiology. Christopher K. Zarins and Charles Anthony Taylor founded Cardiovascular Simulation in 2007 that became HeartFlow in May 2009. Its headquarters is in Redwood City in California.
HeartFlow Announces New Commercial Coverage With UnitedHealthcare, Largest Health Insurer in US
Business Wire (press release) - Jun 27, 2018
HeartFlow's AI coronary test outperforms conventional alternatives
VentureBeat - May 22, 2018
HeartFlow raises $240M to commercialize 3D heart model diagnosis technology
3ders.org (blog) - Feb 16, 2018
HeartFlow Announces Decision by HCSC and Additional BlueCross BlueShield Companies to Issue New Positive ...
Business Wire (press release) - Dec 14, 2017
HeartFlow stakes $90m step toward $150m Series E
Mass Device - Dec 5, 2017
The top 15 healthcare deals of 2016
vator - Nov 3, 2016
Allegheny Health Network Physicians Perform Innovative Procedure to Treat Severe, Uncontrolled Asthma
prweb - Nov 2, 2016
VC Deals Q2 2016
bizjournals - Aug 5, 2016
Global Fractional Flow Reserve Market Report 2016-2020 - Increasing Clinical Trials and Regulatory Approvals - Research and Markets
prnewswire - Jul 19, 2016
Technology from HeartFlow Provides Insights to Help Identify Coronary Plaques at Risk of Rupturing
businesswire - May 19, 2016
- Christopher K. Zarins, Founder, Senior Vice President of Medical Affairs, Member of the Board of Directors
- Charles A. Taylor, Founder, Chief Technology Officer, and Member of the Board of Directors
- John Stevens, CEO
EquityZen does not have an affiliation with, formal relationship with, or endorsement from HeartFlow or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.